Investing.com -- Oppenheimer downgraded Freshpet Inc (NASDAQ:FRPT) to "Perform" from "Outperform," citing a weaker-than-expected start to the year and more cautious management commentary. The firm believes investors should wait for clearer signs of revenue stabilization before considering a potential turnaround.
“We now find it harder to call a bottom in shares and view the risk/reward as balanced,” analyst said as it removed the previous $140 price target.
Oppenheimer has also trimmed its sales estimates for Freshpet, now expecting full-year growth to align with first-quarter trends.
The firm noted that Freshpet shares have historically bottomed at around three times price-to-sales, which could suggest further downside into the $70 range. Given recent momentum at Chewy (NYSE:CHWY), Oppenheimer now views the pet retailer more favorably than Freshpet in the near term.
Despite the downgrade, Oppenheimer still considers Freshpet a potential acquisition target over the longer term.
However, in the current market environment, where investors are shifting away from high-risk names, the firm sees limited upside in the stock.
Freshpet was also removed from Oppenheimer’s top consumer staples picks, which now include more defensive names such as Church&Dwight (NYSE:CHD), Prestige Consumer Healthcare, and Walmart (NYSE:WMT), as well as discretionary stocks like Target and Ulta Beauty (NASDAQ:ULTA).
Although Freshpet has long-term growth drivers, including product innovation, household penetration, and global expansion, Oppenheimer sees near-term challenges.
With disappointing guidance at the recent Consumer Analyst Group of New York (CAGNY) conference and a more cautious tone from management, the firm believes it is prudent to take a wait-and-see approach before expecting a reacceleration in sales.
Related Articles
Oppenheimer downgrades Freshpet on turnaround uncertainty after slow start to year
Puma sees quarterly sales drop on US, China performance
US agency recommends restrictions on helicopters after Washington mid-air collision
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。